Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Ravi Salgia

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Salgia, Ravi

Item TypeName
Concept Treatment Outcome
Concept Treatment Failure
Academic Article Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition.
Academic Article Small cell lung cancer: from molecular biology to novel therapeutics.
Academic Article Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer.
Academic Article Phase II study of imatinib in patients with small cell lung cancer.
Academic Article Therapeutic targeting of the receptor tyrosine kinase Met.
Academic Article Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.
Academic Article c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.
Academic Article c-Met: structure, functions and potential for therapeutic inhibition.
Academic Article Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
Academic Article MET as a target for treatment of chest tumors.
Academic Article EGFR-targeted therapeutics: focus on SCCHN and NSCLC.
Academic Article Biology and novel therapeutics for neuroendocrine tumors of the lung.
Academic Article The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
Academic Article Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunity.
Academic Article MET pathway as a therapeutic target.
Academic Article Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation.
Academic Article Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers.
Academic Article Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer.
Academic Article Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.
Academic Article Mind-mapping for lung cancer: towards a personalized therapeutics approach.
Academic Article Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003).
Academic Article Therapeutic targeting of receptor tyrosine kinases in lung cancer.
Academic Article Multicenter phase II trial of Motexafin gadolinium and pemetrexed for second-line treatment in patients with non-small cell lung cancer.
Academic Article Role of protein kinase C ß and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism.
Academic Article Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancer.
Academic Article c-Met is a potentially new therapeutic target for treatment of human melanoma.
Academic Article Personalized treatment of lung cancer.
Academic Article An E3 ubiquitin ligase: c-Cbl: a new therapeutic target of lung cancer.
Academic Article Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.
Academic Article Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.
Academic Article Novel targets for therapeutic agents in small cell lung cancer.
Academic Article The role of EGFR inhibition in the treatment of non-small cell lung cancer.
Academic Article Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer.
Academic Article RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.
Academic Article Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.
Academic Article Role of MetMAb (OA-5D5) in c-MET active lung malignancies.
Academic Article Quality of life after radical pleurectomy decortication for malignant pleural mesothelioma.
Academic Article The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.
Academic Article A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer.
Academic Article Etoposide and temozolomide in combination for the treatment of progressive small-cell lung cancer central nervous system metastases: two cases.
Academic Article EphB4 as a therapeutic target in mesothelioma.
Academic Article Initial clinical sensitivity and acquired resistance to MET inhibition in MET-mutated papillary renal cell carcinoma.
Academic Article Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibition.
Academic Article Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic.
Academic Article MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma.
Academic Article Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Academic Article O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer.
Academic Article Molecular pathways and therapeutic targets in lung cancer.
Academic Article Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases.
Academic Article Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer.
Academic Article A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization.
Academic Article Biomarkers in lung cancer: from early detection to novel therapeutics and decision making.
Academic Article A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients.
Academic Article A multicenter phase I study of pazopanib in combination with paclitaxel in first-line treatment of patients with advanced solid tumors.
Academic Article A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1).
Academic Article Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib.
Academic Article Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer.
Academic Article Systemic therapies in the treatment of non-small-cell lung cancer brain metastases.
Academic Article Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma.
Academic Article Tumor Heterogeneity and Therapeutic Resistance.
Academic Article Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer.
Academic Article Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.
Academic Article The MET axis as a therapeutic target.
Academic Article Crizotinib (PF02341066) as a ALK /MET inhibitor- Special Emphasis as a Therapeutic Drug Against Lung Cancer.
Academic Article Phase II trial of sequential bevacizumab (B), erlotinib (E) and chemotherapy for first line treatment of clinical stage IIIB or IV non-small cell lung cancer (NSCLC).
Academic Article A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer.
Academic Article Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer.
Academic Article Effective osimertinib treatment in a patient with discordant T790 M mutation detection between liquid biopsy and tissue biopsy.
Academic Article Prostate-Associated Gene 4 (PAGE4): Leveraging the Conformational Dynamics of a Dancing Protein Cloud as a Therapeutic Target.
Academic Article Managing Patients With Relapsed Small-Cell Lung Cancer.
Academic Article Empowering survivors after colorectal and lung cancer treatment: Pilot study of a Self-Management Survivorship Care Planning intervention.
Academic Article Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma.
Academic Article Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma.
Academic Article Combined Checkpoint Inhibition and Chemotherapy: New Era of 1st-Line Treatment for Non-Small-Cell Lung Cancer.
Academic Article Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial Biology.
Academic Article The Mitochondrion as an Emerging Therapeutic Target in Cancer.
Academic Article Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting.
Academic Article Therapeutic targeting of miRNA-216b in cancer.
Academic Article Opportunities for improving cancer treatment using systems biology.
Academic Article Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at Personalized Therapy Strategies.
Academic Article MET receptor in oncology: From biomarker to therapeutic target.
Academic Article Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational Research.
Academic Article The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
Academic Article Rapid progression of disease from immunotherapy following targeted therapy: insights into treatment management and sequence.
Academic Article Therapeutic Potential of Olaparib in Combination With Pembrolizumab in a Young Patient With a Maternally Inherited BRCA2 Germline Variant: A Research Report.
Academic Article RNA-based therapies: A cog in the wheel of lung cancer defense.
Academic Article Targeting the mercapturic acid pathway for the treatment of melanoma.
Academic Article Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer.
Academic Article Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung Cancer.
Academic Article Near-Complete Response to Combined Pembrolizumab and Platinum-Doublet in a Patient With STK11/KRAS Mutated Advanced Lung Adenocarcinoma.
Academic Article Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment.
Academic Article Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma.
Academic Article Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer.
Academic Article Correction: Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer.
Academic Article Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics.

Search Criteria
  • Therapeutics